Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

480
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
480
Depression: Overview01:18

Depression: Overview

678
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
678
Long-term Depression01:03

Long-term Depression

3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression01:05

Long-term Depression

32.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.9K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

674
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
674

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A proof of concept case series of botulinum toxin a treatment for ischemic feet due to Raynaud's phenomenon.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Sulodexide in venous disease.

Journal of thrombosis and haemostasis : JTH·2018
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Clinical science and biomarkers: against RDoC.

Acta psychiatrica Scandinavica·2015
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer's disease.

Pharmacopsychiatry·2015
Same journal

Toward a temperament-based approach to depression: implications for neurobiologic research.

Advances in biochemical psychopharmacology·1995
Same journal

Recent developments in genetics of bipolar illness.

Advances in biochemical psychopharmacology·1995
Same journal

Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry.

Advances in biochemical psychopharmacology·1995
Same journal

Animal models of mania.

Advances in biochemical psychopharmacology·1995
Same journal

Animal models of depression: validity and applications.

Advances in biochemical psychopharmacology·1995
Same journal

The long term prophylaxis of affective disorders.

Advances in biochemical psychopharmacology·1995
See all related articles

Related Experiment Videos

Dexamethasone suppression test for depression.

B J Carroll

    Advances in Biochemical Psychopharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    The Dexamethasone Suppression Test (DST) is a well-tolerated lab test aiding depression diagnosis. It offers high specificity but should be used selectively, not for general screening, to maximize diagnostic confidence.

    Related Experiment Videos

    Area of Science:

    • Clinical diagnostics
    • Psychiatric research
    • Laboratory medicine

    Background:

    • The Dexamethasone Suppression Test (DST) is a practical laboratory diagnostic tool.
    • It is well-tolerated, has no significant side effects, and is unaffected by common psychotropic medications or dietary restrictions.
    • The necessary technology is widely available in hospital settings.

    Purpose of the Study:

    • To evaluate the utility and application of the DST in clinical practice.
    • To determine the sensitivity, specificity, and predictive value of the DST for diagnosing melancholia.
    • To explore the role of the DST in aiding clinicians with the diagnosis and management of depressed patients.

    Main Methods:

    • The DST involves a single-dose administration of dexamethasone.
    • Recommended procedures for inpatient settings were utilized to assess diagnostic accuracy.
    • Sensitivity, specificity, and predictive values were analyzed based on varying prevalence rates of melancholia.

    Main Results:

    • The DST demonstrates good sensitivity (67%) and high specificity (96%) in inpatient settings.
    • The predictive value of an abnormal DST result is high (≥90%) when the prevalence of melancholia is at least 35%.
    • The test's utility is diminished in low-prevalence populations, making it unsuitable for screening unselected patients.

    Conclusions:

    • The DST is a valuable tool for aiding clinicians in diagnosing and managing depression, particularly melancholia, when used judiciously.
    • It should be employed when a specific diagnostic question exists, rather than for broad screening.
    • Interpreting DST results within the overall clinical context is crucial for effective patient care and identifying overlooked depressions.